PARNF

Parnell Pharmaceuticals (CE) (PARNF)

Parnell Pharmaceuticals Holdings Ltd (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PARNF

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
08/07/2017	3:41PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
08/03/2017	12:15PM	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/31/2017	9:36AM	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/21/2017	4:18PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
02/14/2017	11:47AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
01/03/2017	12:09PM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
01/03/2017	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
01/03/2017	6:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/21/2016	2:51PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/21/2016	2:46PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/21/2016	2:40PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/21/2016	2:37PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/21/2016	9:43AM	Edgar (US Regulatory)	(25)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/19/2016	4:31PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/19/2016	4:30PM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/09/2016	5:01PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/09/2016	5:00PM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
12/01/2016	7:01AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
11/30/2016	7:01AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
11/22/2016	10:34PM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
11/02/2016	4:01PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
11/02/2016	4:00PM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
10/27/2016	3:49PM	GlobeNewswire Inc.	Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
08/04/2016	11:37AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
08/04/2016	7:01AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
08/04/2016	7:00AM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
07/26/2016	5:00PM	GlobeNewswire Inc.	Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
05/31/2016	4:07PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
05/31/2016	4:07PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
05/31/2016	4:05PM	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)